Edward J. Dulac III, CFO: Fate Therapeutics FATE Sell · Filed 23/01/11

Trade details

Type: Insider sale
Amount: $38,414.44
Shares · price: 7,331 sh · $5.24 a share
Held after: 129,470 sh
Stock: Fate Therapeutics FATE
Person: Edward J. Dulac IIICFO
Trade date: 23/01/10
Filed: 23/01/11
Days to filing: 1 days

Sold 5.4% of holdings

Share of holding sold: 5.4%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/11~23/02/09

Edward J. Dulac III's recent trades

Edward J. Dulac IIIEVP, CFO
Planned sale10b5-1 planIntellia Therapeutics
Planned sale10b5-1 plan
Intellia Therapeutics
NTLA
$80.6K
4,677 sh
$80.6K
Filed 07/02
Traded 07/02
Edward J. Dulac IIIEVP, CFO
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$58.8K
6,379 sh
$58.8K
Filed 01/07
Traded 01/05
Edward J. Dulac IIIEVP, CFO
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$104.6K
7,462 sh
$104.6K
Filed 25/07/25
Traded 25/07/23
Edward J. Dulac IIICFO
Sell10b5-1 planFate Therapeutics
Sell10b5-1 plan
Fate Therapeutics
FATE
$19K
2,447 sh
$19K
Filed 24/03/05
Traded 24/03/04
Edward J. Dulac IIICFO
Sell10b5-1 planFate Therapeutics
Sell10b5-1 plan
Fate Therapeutics
FATE
$9,245
1,849 sh
$9,245
Filed 24/01/30
Traded 24/01/29